Subxiphoid versus Lateral Intercostal Thoracoscopic Thymectomy for Suspected Thymoma: Results of a Randomized Controlled Trial
Shuai Wang,Xinyu Yang,Jiahao Jiang,Miao Lin,Hong Fan,Zhilong Zhang,Hongwei Xia,Hao Wang,Fei Liang,Jianyong Ding,Lijie Tan
DOI: https://doi.org/10.1016/j.jtcvs.2023.10.040
IF: 6.439
2023-10-28
Journal of Thoracic and Cardiovascular Surgery
Abstract:Objective This trial was to evaluate the efficacy of subxiphoid approach thoracoscopic thymectomy (SATT) for postoperative pain control and length of hospital stay compared with lateral intercostal approach thoracoscopic thymectomy (LATT). Methods This multicenter, open-label, randomized clinical superiority trial enrolled 101 eligible participants clinically diagnosed with Masaoka-Koga I-II thymoma between August 15, 2021, and February 15, 2022. Each enrolled participant was randomized and underwent SATT or LATT. A per-protocol analysis for each coprimary outcome was performed in addition to the main intention-to-treat analysis. Results In the analysis for the coprimary outcomes, the pain visual analog scale (VAS) score area under the curve (AUC) at 0 to 7 days was lower in the SATT group than in the LATT group (difference, -4.82; 98.3% CI, -8.84 to -0.80). However, there was no significant difference between the two groups in the length of hospital stay (difference, 0.318; 98.3% CI, -0.190 to 0.825) or cumulative opioid consumption after surgery (difference, -4.630; 98.3% CI, -9.530 to 0.272). All patients underwent complete resection and there was no significant difference (7.84% vs. 8.00%, p=1.000) in the rate of complications between the two groups. No recurrence or death occurred in the postoperative 6 months. Conclusions This study found improved pain and similar length of hospital stay associated with the subxiphoid approach compared with the lateral intercostal approach in suspected Masaoka-Koga I-II patients.
surgery,cardiac & cardiovascular systems,respiratory system